Melanoma Cancer Breakthrough and Research
Cancer » Melanoma Cancer » Melanoma Cancer Breakthrough and Research
Melanoma cancer breakthrough and research has given an impetus to the aim of getting rid of melanoma cancer. Medical practitioners are learning more about this cancer and trying to evolve new ways of treating this deadly cancer. Methods of detecting this cancer in an early stage are also in progress so that maximum number of lives can be saved. Clinical trials are the most developed aspects in the field of melanoma cancer.
The breakthroughs and research which have taken place in this cancer are
- Prevention and early detection methods: - There has been a continuous research which is going on in the field of medicine for getting to know improved and faster detection methods of this cancer. It is very important to detect melanoma cancer fast so that the life of the patient can be saved and the cancer does not metastasize and make the condition of the patient deteriorate.
- Immunotherapy - Immunotherapy is a therapy in which the immune system of the patient is taken into consideration to fight the cancer which the individual is facing. Like targeted therapy, this too is a major focus area of melanoma cancer breakthrough and research. The current clinical trials have been keeping a track on all the developments which happen in this cancer. Currently, melanoma cancer peptide vaccines are clinically tested for the patients who have cancer in a localized or advanced stage. In this particular research it has been proved that vaccinations can make the immune system to fight against melanoma cancer; even if the cancer has reached an advanced stage. This is a vaccine which is made with the help of proteins which are just specifically found in melanoma, and are used for treating that cancer. This vaccine is given to the patient with the help of an injection and then it works as an activator for the immune system to kill the cancerous cells in the body. The name of the invention is 'Ipiluminab' which is a monoclonal antibody directed against CTLA-4 (cytotoxic T-lymphocyte associated molecule-4).
- Targeted therapy: - Targeted therapy is a treatment which is provided in a specific area only. This is a therapy which is given to the people whose cancer has not spread and is accumulated in one place. This therapy has been a very important area of research by the doctors for melanoma cancer. The current research on melanoma has detected several types of molecular pathways and mutated genes which results melanoma cancer. The most common inclusion in this is mutated gene BRAF as well as activation of the MAP kinase pathway. These two genes are the most common and the most important aspects which cause this cancer in an individual.
- Gene therapy: - This is the latest breakthrough in the field of melanoma cancer. In this type of therapy, the gene is targeted and its code is changed. There are several codes which are present in the person's cells, and thus scientists aim to change it. This is the latest development in the field of treating melanoma, but yet this therapy has shown a promising potential in treating this deadly cancer.
- Chemotherapy: - Under the treatment of chemotherapy too, there have been many inventions in innovating several types of combinations with the help of clinical trials. In addition to this, there have been many anti-angionesis inhibitors which are used in the combinations of this treatment. In addition, the combinations of chemotherapy and drugs that may alter the resistance of melanoma cancer are also currently being explored.
Melanoma cancer breakthrough and research is happening at a fast pace because this is one of the fastest growing cancers. This is a cancer which claims many deaths every year among those suffering from skin cancer. Many types of new developments enabled better treatment of this cancer and it is important to keep on innovating. The biggest drawback of the cancer is that there are no warnings of melanoma cancer, and in most of the cases the cancer is detected at the time it has reached beyond stage 2. This is one of the most important areas of research and some techniques should be developed to treat this cancer at an early stage as well.